Watch Point Trust Co Has $2.87 Million Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

Watch Point Trust Co grew its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 34.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,784 shares of the medical research company’s stock after acquiring an additional 2,531 shares during the period. Watch Point Trust Co’s holdings in Thermo Fisher Scientific were worth $2,873,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the business. Truvestments Capital LLC bought a new position in shares of Thermo Fisher Scientific during the 1st quarter worth about $29,000. Capital Advisors Ltd. LLC boosted its position in shares of Thermo Fisher Scientific by 250.0% during the 2nd quarter. Capital Advisors Ltd. LLC now owns 140 shares of the medical research company’s stock worth $41,000 after purchasing an additional 100 shares in the last quarter. Focused Wealth Management Inc bought a new position in shares of Thermo Fisher Scientific during the 2nd quarter worth about $44,000. Cullen Frost Bankers Inc. bought a new position in shares of Thermo Fisher Scientific during the 1st quarter worth about $64,000. Finally, Bay Harbor Wealth Management LLC boosted its position in shares of Thermo Fisher Scientific by 183.8% during the 2nd quarter. Bay Harbor Wealth Management LLC now owns 227 shares of the medical research company’s stock worth $67,000 after purchasing an additional 147 shares in the last quarter. Hedge funds and other institutional investors own 88.21% of the company’s stock.

In other Thermo Fisher Scientific news, CFO Stephen Williamson sold 2,500 shares of Thermo Fisher Scientific stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $268.29, for a total transaction of $670,725.00. Following the transaction, the chief financial officer now owns 40,029 shares of the company’s stock, valued at approximately $10,739,380.41. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $284.83, for a total transaction of $14,241,500.00. Following the transaction, the chief executive officer now directly owns 342,193 shares in the company, valued at approximately $97,466,832.19. The disclosure for this sale can be found here. In the last three months, insiders have sold 52,775 shares of company stock worth $14,986,676. Insiders own 0.45% of the company’s stock.

Shares of Thermo Fisher Scientific stock traded up $3.86 during mid-day trading on Thursday, hitting $273.34. 42,901 shares of the stock were exchanged, compared to its average volume of 1,592,969. Thermo Fisher Scientific Inc. has a 12 month low of $208.34 and a 12 month high of $305.45. The firm’s 50-day moving average is $287.70. The company has a quick ratio of 1.07, a current ratio of 1.49 and a debt-to-equity ratio of 0.58. The stock has a market capitalization of $108.93 billion, a P/E ratio of 24.54, a P/E/G ratio of 1.78 and a beta of 1.11.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, July 24th. The medical research company reported $3.04 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.01 by $0.03. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.11%. The firm had revenue of $6.32 billion for the quarter, compared to analysts’ expectations of $6.31 billion. During the same quarter last year, the firm earned $2.75 EPS. The company’s quarterly revenue was up 3.9% compared to the same quarter last year. On average, research analysts predict that Thermo Fisher Scientific Inc. will post 12.24 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Tuesday, September 17th will be given a dividend of $0.19 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $0.76 annualized dividend and a dividend yield of 0.28%. Thermo Fisher Scientific’s dividend payout ratio is currently 6.83%.

TMO has been the topic of several recent research reports. Needham & Company LLC raised their price target on shares of Thermo Fisher Scientific from $315.00 to $321.00 and gave the company a “buy” rating in a research report on Thursday, July 25th. Credit Suisse Group reaffirmed a “buy” rating and issued a $310.00 price target on shares of Thermo Fisher Scientific in a research report on Wednesday, July 31st. Argus raised their price target on shares of Thermo Fisher Scientific from $285.00 to $310.00 and gave the company a “buy” rating in a research report on Wednesday, May 1st. Wolfe Research initiated coverage on shares of Thermo Fisher Scientific in a research report on Thursday, May 30th. They issued an “outperform” rating on the stock. Finally, UBS Group raised their price target on shares of Thermo Fisher Scientific from $305.00 to $320.00 and gave the company a “buy” rating in a research report on Thursday, May 23rd. Two research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $303.17.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Article: Bid-Ask Spread

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.